Healthtech Series A Investors & VC Firms
2309 firms in this list, with a median first check of $500K. 550 of them lead rounds. Generated from verified public data and updated continuously.
AgeTech Capital
TorontoSeed–Growth
16 people
FemHealth Ventures
Short HillsSeed–Series A
10 people
Furthr VC
DublinSeed–Series A$54K – $270K
4 people
E12 Venture Capital, Llc
Los AltosSeed–Series B
14 people
Germin8 Ventures
ChicagoSeed–Series B
9 people
LifeArc Ventures
LondonSeed–Series A
12 people
Revere Partners
Seed–Series B
15 people
Santen Pharmaceutical
OsakaSeries A–Series C
24 people
Sentiero Ventures
DallasPre-Seed–Series A$10K – $1M
9 people
Viessmann Generations Group
Battenberg (Eder)Seed–Late Stage
12 people
Wildcat Venture Partners
San MateoSeed–Series B$500K – $6M
7 people
Cowin Capital Group
ShenzhenSeed–Series A
11 people
Lifetime Ventures
OkinawaPre-Seed–Growth
5 people
Nimbus Synergies Inc.
VancouverPre-Seed–Series A$250K – $2M
14 people
Propel Bio Partners
Los AngelesSeed–Series A
17 people
Riverfront Ventures, LLC
PittsburghSeed–Series A$250K – $1M
8 people
Latterell Venture Partners
San RamonSeed–Series A$50K – $10M
6 people
Tamiami Angel
NaplesSeed–Series A
1 person
Heran Partners
AntwerpSeed–Series B
13 people
MFV Partners
San Francisco Bay AreaPre-Seed–Series A$1M – $5M
7 people
Claris Ventures
TorinoSeed–Series A
14 people
Bootstrap Venture Partners
Solana BeachSeed–Series A
6 people
Impact India Investment Partners
MumbaiPre-Seed–Series A$150K – $1M
12 people
Morado Ventures
Los AltosSeed–Series A$150K
4 people
Related lists
Series A Investors & VC Firms (7325)Series A Investors & VC Firms in North America (4219)Healthtech Investors & VC Firms (4190)Series A Investors & VC Firms in United States (3838)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2665)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2590)Healthtech Investors & VC Firms in United States (2436)Series A Investors & VC Firms in Europe (2383)
Data sourced from public filings and firms' own websites — see our methodology.






























































































